Related Experiment Video
Updated: Jan 15, 2026

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
Published on: May 12, 2018
Pain, Analgesia, Sedation, and the Developing Brain
Callie Marshall1, Christopher McPherson2
1Department of Pediatrics, Washington University/St. Louis Children's Hospital, St Louis, MO, USA.
Insights
Neonatal pain significantly impacts long-term development, yet optimal assessment and treatment strategies are still evolving. Clinicians must balance evidence-based efficacy with crucial safety considerations for effective pain management in infants.
Area of Science:
- Neonatal care
- Developmental neuroscience
- Pain management
Background:
- Neonatal pain is known to affect brain development and long-term outcomes.
- Current evidence on optimal pain assessment and treatment in clinical practice is incomplete.
Purpose of the Study:
- To review and synthesize evidence on neonatal pain assessment and management.
- To guide clinicians in prioritizing safety and efficacy in clinical scenarios.
Main Methods:
- Literature synthesis of existing evidence on neonatal pain.
- Analysis of nonpharmacologic and pharmacologic intervention strategies.
- Evaluation of safety considerations for pain management.
Main Results:
- Nonpharmacologic interventions should be systematic, safe, and involve parents.
- Pharmacologic interventions for procedures require protocolization based on stimulus.
- Safe options for prolonged neonatal pain and agitation are limited and require caution.
Conclusions:
- Clinicians must integrate available evidence, prioritizing safety in neonatal pain management.
- Systematic, parent-inclusive nonpharmacologic approaches are recommended.
- Cautious, protocolized pharmacologic interventions are necessary, especially for prolonged pain.
Abstract:
Robust evidence informs our understanding of the impacts of neonatal pain on brain growth and development and outcomes in childhood and adult life. However, evidence regarding optimal assessment and treatment in common clinical scenarios remains incomplete. In this setting, clinicians must synthesize available evidence regarding efficacy, and prioritize safety. Nonpharmacologic interventions should be systematic, safely implemented, and incorporate parents, when possible. Pharmacologic interventions should be protocolized for painful procedures, reflecting the magnitude and duration of the painful stimulus. Safe options for prolonged pain and agitation remain elusive and must be implemented with caution regarding both dose and duration.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Analgesia and Pain Management
Stages of General Anesthesia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...

